Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 72

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Genomic analysis of fibrolamellar hepatocellular carcinoma

Xu, Lei, Hazard, Florette K., Zmoos, Anne-Flore, Jahchan, Nadine, Chaib, Hassan, Garfin, Phillip M., Rangaswami, Arun, Snyder, Michael P., Sage, Julien · 2015 · Human Molecular Genetics

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/hmg/ddu418

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 66

  1. 2007, Hepatocellular carcinoma: epidemiology and molecular carcinogenesis, Gastroenterology, 132, 2557, 10.1053/j.gastro.2007.04.061 · DOI · Paper page
  2. 2013, Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma, Nat. Rev. Cancer, 13, 123, 10.1038/nrc3449 · DOI · Paper page
  3. 2005, Primary liver carcinoma arising in people younger than 30 years, Am. J. Clin. Pathol., 124, 512, 10.1309/TT0R7KAL32228E99 · doi:10.1309/tt0r7kal32228e99
  4. 2011, Fibrolamellar carcinoma: a review with focus on genetics and comparison to other malignant primary liver tumors, Semin. Liver Dis., 31, 61, 10.1055/s-0031-1272835 · doi:10.1055/s-0031-1272835
  5. 2004, Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study, Hepatology, 39, 798, 10.1002/hep.20096 · DOI
  6. 2005, Clinicopathologic features and survival in fibrolamellar carcinoma: comparison with conventional hepatocellular carcinoma with and without cirrhosis, Mod. Pathol., 18, 1417, 10.1038/modpathol.3800449 · doi:10.1038/modpathol.3800449
  7. 1980, Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinico-pathologic features, Cancer, 46, 372, 10.1002/1097-0142(19800715)46:2<372::AID-CNCR2820460227>3.0.CO;2-S · doi:10.1002/1097-0142(19800715)46:2<372::aid-cncr2820460227>3.0.co;2-s
  8. 2009, Fibrolamellar hepatocellular carcinoma, Am. J. Gastroenterol., 104, 2617, 10.1038/ajg.2009.440 · DOI
  9. 2008, EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma, Cancer Res., 68, 1451, 10.1158/0008-5472.CAN-07-6013 · DOI · Paper page
  10. 2010, Fibrolamellar carcinoma of the liver exhibits immunohistochemical evidence of both hepatocyte and bile duct differentiation, Mod. Pathol., 23, 1180, 10.1038/modpathol.2010.105 · doi:10.1038/modpathol.2010.105
  11. 2011, Fibrolamellar carcinomas are positive for CD68, Mod. Pathol., 24, 390, 10.1038/modpathol.2010.207 · doi:10.1038/modpathol.2010.207
  12. 2013, Sal-like protein 4 (SALL4), a stem cell biomarker in liver cancers, Hepatology, 57, 1469, 10.1002/hep.26159 · DOI · Paper page
  13. 1990, Abundant expression of cytokeratin 7 in fibrolamellar carcinoma of the liver, Histopathology, 17, 101, 10.1111/j.1365-2559.1990.tb00679.x · doi:10.1111/j.1365-2559.1990.tb00679.x
  14. 2007, Fibrolamellar carcinomas show overexpression of genes in the RAS, MAPK, PIK3, and xenobiotic degradation pathways, Hum. Pathol., 38, 639, 10.1016/j.humpath.2006.07.019 · doi:10.1016/j.humpath.2006.07.019
  15. 2006, Epidermal growth factor receptor expression and gene copy number in fibrolamellar hepatocellular carcinoma, Hum. Pathol., 37, 410, 10.1016/j.humpath.2005.12.009 · DOI
  16. 2009, Unique phenotype of hepatocellular cancers with exon-3 mutations in beta-catenin gene, Hepatology, 49, 821, 10.1002/hep.22695 · DOI · Paper page
  17. 1997, Lamellar fibrosis in the fibrolamellar variant of hepatocellular carcinoma: a role for transforming growth factor beta, Liver, 17, 152, 10.1111/j.1600-0676.1997.tb00798.x · doi:10.1111/j.1600-0676.1997.tb00798.x
  18. 2010, Constitutive activation of nuclear factor-kappa B (NF-kB) signaling pathway in fibrolamellar hepatocellular carcinoma, Int. J. Clin. Exp. Pathol., 3, 238
  19. 2012, Loss of the orphan nuclear receptor SHP is more pronounced in fibrolamellar carcinoma than in typical hepatocellular carcinoma, PLoS ONE, 7, e30944, 10.1371/journal.pone.0030944 · doi:10.1371/journal.pone.0030944
  20. 2014, Prognosis of patients with fibrolamellar hepatocellular carcinoma versus conventional hepatocellular carcinoma: a systematic review and meta-analysis, Gastrointest. Cancer Res., 7, 49
  21. 1995, Fibrolamellar hepatocellular carcinoma: stage at presentation and results of aggressive surgical management, AJR Am. J. Roentgenol., 164, 1153, 10.2214/ajr.164.5.7717223 · doi:10.2214/ajr.164.5.7717223
  22. 2003, Fibrolamellar hepatocellular carcinoma in children and adolescents, Cancer, 97, 2006, 10.1002/cncr.11292 · DOI
  23. 2013, Clinicopathologic characteristics and survival outcomes of patients with fibrolamellar carcinoma: data from the fibrolamellar carcinoma consortium, Gastrointest. Cancer Res., 6, 3
  24. 2013, Fibrolamellar variant of hepatocellular carcinoma, Recent Results Cancer Res., 190, 101, 10.1007/978-3-642-16037-0_7 · doi:10.1007/978-3-642-16037-0_7
  25. 2014, Detection of a recurrent DNAJB1-PRKACA chimeric transcript in fibrolamellar hepatocellular carcinoma, Science, 343, 1010, 10.1126/science.1249484 · DOI · Paper page
  26. 2009, Anterior gradient-2 is overexpressed by fibrolamellar carcinomas, Hum. Pathol., 40, 293, 10.1016/j.humpath.2008.08.003 · doi:10.1016/j.humpath.2008.08.003
  27. 1984, Neurotensin secretion by fibrolamellar carcinoma of the liver, Lancet, 1, 538
  28. 1991, ‘Neuroendocrine’ differentiation in primary neoplasms of the liver, J. Pathol., 163, 61, 10.1002/path.1711630111 · doi:10.1002/path.1711630111
  29. 2014, Transcriptional profiling of pure fibrolamellar hepatocellular carcinoma reveals an endocrine signature, Hepatology, 59, 2228, 10.1002/hep.27018 · DOI
  30. 1993, Infrequent chromosome allele loss in fibrolamellar carcinoma, Br. J. Cancer, 67, 244, 10.1038/bjc.1993.47 · doi:10.1038/bjc.1993.47
  31. 2012, Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma, Nat. Genet., 44, 694, 10.1038/ng.2256 · DOI · Paper page
  32. 2012, Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators, Nat. Genet., 44, 760, 10.1038/ng.2291 · DOI · Paper page
  33. 2012, Exome sequencing of hepatitis B virus-associated hepatocellular carcinoma, Nat. Genet., 44, 1117, 10.1038/ng.2391 · DOI · Paper page
  34. 2013, Cancer genome landscapes, Science, 339, 1546, 10.1126/science.1235122 · DOI · Paper page
  35. 2000, Distinct chromosomal abnormality pattern in primary liver cancer of non-B, non-C patients, Oncogene, 19, 3733, 10.1038/sj.onc.1203713 · doi:10.1038/sj.onc.1203713
  36. 2000, Cytogenetic aberrations in primary and recurrent fibrolamellar hepatocellular carcinoma detected by comparative genomic hybridization, Am. J. Clin. Pathol., 114, 867, 10.1309/BMTT-JBPD-D13H-1UVD · doi:10.1309/bmtt-jbpd-d13h-1uvd
  37. 1992, Intracellular localization and partial amino acid sequence of a stress-inducible 40-kDa protein in HeLa cells, Cell Struct. Funct., 17, 77, 10.1247/csf.17.77 · DOI
  38. 2006, Oscillations of cyclic AMP in hormone-stimulated insulin-secreting beta-cells, Nature, 439, 349, 10.1038/nature04410 · DOI · Paper page
  39. 2009, Sequence variants at the TERT-CLPTM1L locus associate with many cancer types, Nat. Genet., 41, 221, 10.1038/ng.296 · DOI · Paper page
  40. 2006, Mutations in GLIS3 are responsible for a rare syndrome with neonatal diabetes mellitus and congenital hypothyroidism, Nat. Genet., 38, 682, 10.1038/ng1802 · DOI · Paper page
  41. 2009, The cancer genome, Nature, 458, 719, 10.1038/nature07943 · DOI · Paper page
  42. 2014, The prenatal origins of cancer, Nat. Rev. Cancer, 14, 277, 10.1038/nrc3679 · DOI · Paper page
  43. 2012, A novel retinoblastoma therapy from genomic and epigenetic analyses, Nature, 481, 329, 10.1038/nature10733 · DOI · Paper page
  44. 1992, Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: a Cancer and Leukemia Group B Study (8762), Blood, 80, 2983, 10.1182/blood.V80.12.2983.2983 · DOI · Paper page
  45. 1993, Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations, N. Engl. J. Med., 329, 909, 10.1056/NEJM199309233291302 · DOI · Paper page
  46. 1994, Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma, Cancer Res., 54, 2869
  47. 1994, A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG, Nat. Genet., 6, 146, 10.1038/ng0294-146 · DOI · Paper page
  48. 1995, Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia, Proc. Natl. Acad. Sci. USA, 92, 4917, 10.1073/pnas.92.11.4917 · DOI · Paper page
  49. 1996, In vivo amplification of the PAX3-FKHR and PAX7-FKHR fusion genes in alveolar rhabdomyosarcoma, Hum. Mol. Genet., 5, 15, 10.1093/hmg/5.1.15 · DOI
  50. 1998, ETV6-NTRK3 gene fusions and trisomy 11 establish a histogenetic link between mesoblastic nephroma and congenital fibrosarcoma, Cancer Res., 58, 5046
  51. 1998, NUP98-HOXD13 gene fusion in therapy-related acute myelogenous leukemia, Cancer Res., 58, 4269
  52. 1999, The role of TEL fusion genes in pediatric leukemias, Leukemia, 13, 6, 10.1038/sj.leu.2401258 · DOI
  53. 2003, A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23), Oncogene, 22, 5374, 10.1038/sj.onc.1206686 · DOI · Paper page
  54. 2014, Fusion of TTYH1 with the C19MC microRNA cluster drives expression of a brain-specific DNMT3B isoform in the embryonal brain tumor ETMR, Nat. Genet., 46, 39, 10.1038/ng.2849 · DOI · Paper page
  55. 1984, Chromosome rearrangements in oncogenesis, Microbiol. Sci., 1, 223
  56. 2010, Genotype-phenotype relationship in three cases with overlapping 19p13.12 microdeletions, Eur. J. Hum. Genet., 18, 1302, 10.1038/ejhg.2010.115 · DOI
  57. 2013, A drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumors, Cancer Discov., 3, 1364, 10.1158/2159-8290.CD-13-0183 · DOI · Paper page
  58. 2007, Androgen-independent growth and tumorigenesis of prostate cancer cells are enhanced by the presence of PKA-differentiated neuroendocrine cells, Cancer Res., 67, 3663, 10.1158/0008-5472.CAN-06-2616 · DOI
  59. 2013, p21-Activated kinase 4 promotes prostate cancer progression through CREB, Oncogene, 32, 2475, 10.1038/onc.2012.255 · DOI
  60. 2014, Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors, Nat. Genet., 46, 613, 10.1038/ng.2956 · DOI · Paper page
  61. 2014, Recurrent somatic mutations underlie corticotropin-independent Cushing's syndrome, Science, 344, 917, 10.1126/science.1252328 · DOI · Paper page
  62. 2009, Chromosomal changes in fibrolamellar hepatocellular carcinoma detected by array comparative genomic hybridization, Mod. Pathol., 22, 134, 10.1038/modpathol.2008.178 · doi:10.1038/modpathol.2008.178
  63. 2010, Frequent and distinct aberrations of DNA methylation patterns in fibrolamellar carcinoma of the liver, PLoS ONE, 5, e13688, 10.1371/journal.pone.0013688 · DOI
  64. 2010, Mitochondrial mutations in hepatocellular carcinomas and fibrolamellar carcinomas, Mod. Pathol., 23, 790, 10.1038/modpathol.2010.51 · DOI
  65. 2011, A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer, Nat. Genet., 43, 1210, 10.1038/ng.985 · DOI · Paper page
  66. 2008, Hematopoietic stem cell quiescence is maintained by compound contributions of the retinoblastoma gene family, Cell Stem Cell, 3, 416, 10.1016/j.stem.2008.07.009 · DOI · Paper page

Cited by

See all 72

Metadata

Authors
Xu, L., Hazard, F. K., Zmoos, A.-F., Jahchan, N., Chaib, H., Garfin, P. M., Rangaswami, A., Snyder, M. P., & Sage, J.
Venue
Human Molecular Genetics
Published
2014-08-13
Volume
24
Issue
1
Pages
50-63
ISSN
  • 0964-6906
  • 1460-2083
Cited by
72
References
3
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Genomic analysis of fibrolamellar hepatocellular carcinoma. https://app.cochat.ai/papers/10.1093/hmg/ddu418
The paper
Xu, L., Hazard, F. K., Zmoos, A.-F., Jahchan, N., Chaib, H., Garfin, P. M., Rangaswami, A., Snyder, M. P., & Sage, J. (2015). Genomic analysis of fibrolamellar hepatocellular carcinoma. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddu418

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.